ARCHIVES

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

George Sledge Jr. Named Oncology Chief at Stanford University

October 12, 2012

Penn Begins Clinical Trial Of A Vaccine For Breast Cancer Based On Telomerase

February 27, 2004

FDA To Regulate Products From Human Cells, Tissue

March 21, 1997

Research Teams Win Honors For Cancer Immunotherapy Work

October 15, 2010

Lombardi Center Officials Say New Partnership To Provide For Expansion In Services, Patients.

February 23, 2001

DRCCA Board, Subcommittee Approve Reorganization Of Education Program

February 5, 1982